Cargando...
The Role of Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma: An Update
Sorafenib is the first and only orally administered drug currently approved to treat advanced hepatocellular carcinoma (HCC). However, concerns have been raised about sorafenib therapy, including acquired drug resistance. This review provides an overview of sorafenib in the treatment of HCC on the b...
Gardado en:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2012
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3574194/ https://ncbi.nlm.nih.gov/pubmed/23145926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1872-034X.2012.01113.x |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|